B.J. Rimel, MD of Cedars Sinai Medical Center discusses the SGO Presidential address and how inspirational it was from SGO…
Browsing: Acute Lymphoblastic Leukemia
B.J. Rimel, MD of Cedars Sinai Medical Center discusses the high number of uterine and BRCA mutations from study focusing…
B.J. Rimel, MD of Cedars Sinai Medical Center discusses the future clinical trials in ovarian cancer from SGO 2016. Transcription:…
Karen H. Lu, MD of MD Anderson discusses recommendations to physicians whos patients are concerned about their risk of ovarian…
Karen H. Lu, MD of MD Anderson discusses how genetic testing improves early detection of BRCA in at risk women…
Karen H. Lu, MD of MD Anderson discusses genomic analysis and prophylactic surgical management for women with inherited genetic abnormalities…
Karen H. Lu, MD of MD Anderson discusses genetic counseling and prophylactic measures for women at high risk for ovarian…
Karen H. Lu, MD of MD Anderson says that all women with ovarian cancer should undergo genomic testing for BRCA…
Thomas Herzog, MD of UC Health discusses preoperative staging and likelihood of R0 resection in gynecologic cancer at SGO 2016.
Thomas Herzog, MD of UC Health discusses neoadjuvant regimen for patients with ovarian cancer at SGO 2016.
Thomas Herzog, MD of UC Health discusses GOG-172 and the ability to modify the Armstrong regimen for greater tolerability at…
Thomas Herzog, MD of UC Health discusses neoadjuvant chemotherapy compromise postoperative recovery at SGO 2016.
Thomas Herzog, MD of UC Health discusses age and the decision to use intraperitoneal chemotherapy in ovarian cancer at SGO…
Martee L. Hensley, MD of Memorial Sloan Kettering discusses how trabectedin improves PFS over Dacarbazine in uterine leiomyosarcoma at SGO…
Martee L. Hensley, MD of Memorial Sloan Kettering discusses trabectedin improves patients with drug resistant metastatic leiomyosarcoma at SGO 2016.
Martee L. Hensley, MD of Memorial Sloan Kettering discusses gynecologic cancer treatment trends at SGO 2016.
Martee L. Hensley, MD of Memorial Sloan Kettering discusses GOG-86P results and genetic testing among most notable data released at…
Martee L. Hensley, MD of Memorial Sloan Kettering discusses genomic analysis and immunotherapy are treatments to watch in gynecologic malignancies…
Michael J. Birrer, MD of Massachusetts General Hospital discusses toxicities of anti-PD-1 and anti-PD-L1 in gynecologic cancers at SGO 2016.…
Michael J. Birrer, MD of Massachusetts General Hospital discusses the unique side effects of trabectedin at SGO 2016. Transcription: The…
Michael J. Birrer, MD of Massachusetts General Hospital discusses promising immunotherapy currently under evaluation for advance gynecologic cancers at SGO…
Is there a reliable test to determine whether a patient has a tendency to develop blood clots? Andrew Schorr asks…
Michael J. Birrer, MD of Massachusetts General Hospital discusses PDL-1 and immune checkpoint inhibitors in endometrial cancer at SGO 2016.…
The international Consensus Conference for Advanced Breast Cancer (ABC) has established itself as a major international breast cancer conference. Its…
Michael J. Birrer, MD of Massachusetts General Hospital discusses ovarian cancer is targetable with PARP inhibitors at SGO 2016. Transcription:…
Michael J. Birrer, MD of Massachusetts General Hospital discusses multiplex testing and next generation sequencing in metastatic ovarian cancer at…
Michael J. Birrer, MD of Massachusetts General Hospital discusses mirvetuximab soravtansin side effects compared to other systemic treatments in heavily…
Michael J. Birrer, MD of Massachusetts General Hospital discusses HPV-related cervical cancer with anti-PD-1 and anti-PDL-1 antibodies at SGO 2016.…
Michael J. Birrer, MD of Massachusetts General Hospital discusses guidelines for micro satellite instability or MSI testing for endometrial patients…
Michael J. Birrer, MD of Massachusetts General Hospital discusses current actionable mutations in advanced ovarian cancer at SGO 2016. Transcription:…
Elizabeth Swisher MD of the University Of Washington discusses Vice President Bidens initiative to increase clinical trials for women with…
Elizabeth Swisher MD of the University Of Washington discusses using Next Generation Genetic Sequencing to determine what fraction of ovarian…
Elizabeth Swisher MD of the University Of Washington discusses ovarian cancer focus for 2016 to include genetic analysis and target…
Elizabeth Swisher MD of the University Of Washington discusses how genomic analysis will strengthen prophylactic surgical management in inherited genetic…
Elizabeth Swisher MD of the University Of Washington discusses how genomic analysis may improve prevention, screening and management of inherited…
Elizabeth Swisher MD of the University Of Washington discusses the clinical factors for requesting a genomic analysis for at risk…
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe…
Triple-negative breast cancer (TNBC) represents a biologically and clinically heterogeneous disease. At the 10th European Breast Cancer Conference (EBCC), held…
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima…
At the German Cancer Congress 2016, held in Berlin, Germany from 24 to 27 February 2016, Viktor Grünwald, MD, PhD,…
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Martin Reck, MD, PhD,…
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Matthias Löhr, MD, PhD,…
At the German Cancer Congress 2016, held in Berlin, Germany from 24 to 27 February 2016, Viktor Grünwald, MD, PhD,…
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Martin Reck, MD, PhD,…
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Matthias Löhr, MD, PhD,…
Why are researchers and physicians so excited about combination CLL therapy? Patient Power Founder Andrew Schorr sits down with CLL…
In this Ask the Expert segment, MPN expert Dr. Naval Daver of MD Anderson Cancer Center explains why the current…
Why are researchers and physicians so excited about combination CLL therapy? Patient Power Founder Andrew Schorr sits down with CLL…
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Christoph Röllig, MD, from…
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Wolfgang Hiddemann, MD, PhD,…